Wahlgren M, Berzins K, Perlmann P, Björkman A
Clin Exp Immunol. 1983 Oct;54(1):127-34.
An enzyme linked immunosorbent assay (ELISA) has been developed to estimate disease related antibodies in sera from malaria patients or individuals living in malaria endemic areas. As antigen, Percoll enriched fractions (mainly late trophozoites, schizonts) from Plasmodium falciparum in vitro cultures were used. An ELISA with ghosts from normal human red blood cells (RBC) was performed in parallel. One hundred and seventy-five sera were tested for their reactivity with either one of the two antigens. Seven sera from patients with acute P. falciparum infection were negative. Most of these had been taken very early in infection and consecutive samples taken later usually were positive. The antibodies reacting with the P. falciparum antigen had a high parasite specificity as indicated by inhibition and absorption experiments. Many sera also had elevated levels of antibodies specific for RBC antigens. A correlation, most pronounced in the IgM system, was also seen between the anti-RBC and the anti-P. falciparum antibody levels.
已开发出一种酶联免疫吸附测定(ELISA)法,用于评估疟疾患者或生活在疟疾流行地区的个体血清中与疾病相关的抗体。作为抗原,使用了体外培养的恶性疟原虫经Percoll富集的组分(主要是晚期滋养体、裂殖体)。同时进行了用人正常红细胞(RBC)空壳的ELISA检测。对175份血清检测了它们与两种抗原中任一种的反应性。7份急性恶性疟原虫感染患者的血清呈阴性。其中大多数血清是在感染早期采集的,随后采集的连续样本通常呈阳性。抑制和吸收实验表明,与恶性疟原虫抗原反应的抗体具有较高的寄生虫特异性。许多血清中针对RBC抗原的抗体水平也有所升高。在抗RBC抗体和抗恶性疟原虫抗体水平之间也存在相关性,在IgM系统中最为明显。